Leadership and impact
I combine mechanistic immunology with researcher development, collaborative programme building and therapeutic translation. My ambition is to establish a team that connects rigorous discovery science with the development of Reconstructive Immunotherapy.
Developing researchers
My supervision experience includes co-supervision of Oxford DPhil researchers Charles Coomer and Olga Margaritaki, alongside undergraduate and Master’s research projects across Oxford, Utrecht, Leiden and Siena. My support spans experimental strategy, technical development, data interpretation, scientific writing and career development.
I teach Biochemistry through my Associate Lecturer role at Magdalen College, Oxford, and have contributed to Immunology teaching through the Oxford Immunology Teaching Network. I aim to help researchers develop independent judgement while building the practical skills to test ideas rigorously.
Building programmes and securing research support
I have been lead applicant for OCION proof-of-concept support, the University of Oxford John Fell Fund and Diamond Light Source proposal BI30452, and a co-applicant on an NIH R01 collaboration. These experiences span exploratory research, access to specialist infrastructure and translational development.
My collaborative work brings together immunology, advanced imaging, membrane biology and cellular engineering. The research case studies describe specific findings and my documented contributions, from T-cell receptor trafficking to tumour immune suppression and multifunctional regulatory T cells.
Connecting discovery with biotechnology
My experience includes scientific advisory work with Aluda Pharmaceuticals and Linseg Technologies, connecting mechanistic research with experimental strategy and technology development.
Through Oxford Venture Builder in 2025, I developed the commercialisation strategy around the CyTrex research direction and gained experience in intellectual property, freedom-to-operate and therapeutic positioning. I also completed EMBO Laboratory Leadership training in 2025.
For discovery-focused biotech leadership, I bring a research approach that connects mechanism of action, quantitative functional assays and relevant human disease environments. My proposed development strategy would use explicit milestones to test both the therapeutic activity and environmental resilience of candidate immune-cell approaches.
Strengthening research culture
I co-founded CONNECTS-UK and served as a founding director and treasurer of the Dutch academic network in the UK. I founded and chaired Young-NVVI to strengthen early-career representation in immunology.
At the Kennedy Institute, my service has included chairing the Postdoctoral Committee and working as a departmental Bullying and Harassment Adviser. As an eLife Ambassador and contributor to research-culture initiatives, I have advocated for transparent research, reproducibility and meaningful participation by early-career scientists.
Explore my work on open science and research culture →
The team I want to build
My proposed independent programme brings together immune-cell biology, bioengineering and disease-focused collaboration. I would build a team around clear scientific questions, reproducible experimental systems, supportive supervision and decisions grounded in functional evidence.
I welcome conversations about principal investigator and group-leader positions, discovery-focused biotech scientific leadership, and partnerships to develop Reconstructive Immunotherapy.
Explore the research case studies · About my research · Discuss an opportunity